Click for best price
Cardiac Biomarkers Testing Market Size, Share 2023
| Market size in 2022 |
US$ 7339.2 million
|
Forecast Market size by 2029 |
US$ 11200 million
|
| Growth Rate |
CAGR of 6.2% |
Number of Pages |
68 Pages |
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart.
This report aims to provide a comprehensive presentation of the global market for Cardiac Biomarkers Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Biomarkers Testing. This report contains market size and forecasts of Cardiac Biomarkers Testing in global, including the following market information:
Global Cardiac Biomarkers Testing Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cardiac Biomarkers Testing market was valued at US$ 7339.2 million in 2022 and is projected to reach US$ 11200 million by 2029, at a CAGR of 6.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
We surveyed the Cardiac Biomarkers Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiac Biomarkers Testing Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cardiac Biomarkers Testing Market Segment Percentages, by Type, 2022 (%)
Myocardial Muscle Creatine Kinase (CK-MB)
Troponins (T and I)
Myoglobin
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia-modified Albumin (IMA)
Others
Global Cardiac Biomarkers Testing Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cardiac Biomarkers Testing Market Segment Percentages, by Application, 2022 (%)
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
Global Cardiac Biomarkers Testing Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cardiac Biomarkers Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardiac Biomarkers Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cardiac Biomarkers Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Danaher Corporation
ROCHE
Siemens AG
Thermo Fisher Scientific, Inc.
PerkinElmer Inc.
Tosoh Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cardiac Biomarkers Testing, market overview.
Chapter 2: Global Cardiac Biomarkers Testing market size in revenue.
Chapter 3: Detailed analysis of Cardiac Biomarkers Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cardiac Biomarkers Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cardiac Biomarkers Testing Market, Global Outlook and Forecast 2023-2030 |
| Market size in 2022 |
US$ 7339.2 million
|
| Forecast Market size by 2029 |
US$ 11200 million
|
| Growth Rate |
CAGR of 6.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cardiac Biomarkers Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cardiac Biomarkers Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cardiac Biomarkers Testing Overall Market Size
2.1 Global Cardiac Biomarkers Testing Market Size: 2022 VS 2030
2.2 Global Cardiac Biomarkers Testing Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cardiac Biomarkers Testing Players in Global Market
3.2 Top Global Cardiac Biomarkers Testing Companies Ranked by Revenue
3.3 Global Cardiac Biomarkers Testing Revenue by Companies
3.4 Top 3 and Top 5 Cardiac Biomarkers Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cardiac Biomarkers Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cardiac Biomarkers Testing Players in Global Market
3.6.1 List of Global Tier 1 Cardiac Biomarkers Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Cardiac Biomarkers Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cardiac Biomarkers Testing Market Size Markets, 2022 & 2030
4.1.2 Myocardial Muscle Creatine Kinase (CK-MB)
4.1.3 Troponins (T and I)
4.1.4 Myoglobin
4.1.5 Brain Natriuretic Peptide (BNPs) or NT-proBNP
4.1.6 Ischemia-modified Albumin (IMA)
4.1.7 Others
4.2 By Type - Global Cardiac Biomarkers Testing Revenue & Forecasts
4.2.1 By Type - Global Cardiac Biomarkers Testing Revenue, 2018-2023
4.2.2 By Type - Global Cardiac Biomarkers Testing Revenue, 2024-2030
4.2.3 By Type - Global Cardiac Biomarkers Testing Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cardiac Biomarkers Testing Market Size, 2022 & 2030
5.1.2 Myocardial Infarction
5.1.3 Congestive Heart Failure
5.1.4 Acute Coronary Syndrome
5.1.5 Atherosclerosis
5.1.6 Others
5.2 By Application - Global Cardiac Biomarkers Testing Revenue & Forecasts
5.2.1 By Application - Global Cardiac Biomarkers Testing Revenue, 2018-2023
5.2.2 By Application - Global Cardiac Biomarkers Testing Revenue, 2024-2030
5.2.3 By Application - Global Cardiac Biomarkers Testing Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cardiac Biomarkers Testing Market Size, 2022 & 2030
6.2 By Region - Global Cardiac Biomarkers Testing Revenue & Forecasts
6.2.1 By Region - Global Cardiac Biomarkers Testing Revenue, 2018-2023
6.2.2 By Region - Global Cardiac Biomarkers Testing Revenue, 2024-2030
6.2.3 By Region - Global Cardiac Biomarkers Testing Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cardiac Biomarkers Testing Revenue, 2018-2030
6.3.2 US Cardiac Biomarkers Testing Market Size, 2018-2030
6.3.3 Canada Cardiac Biomarkers Testing Market Size, 2018-2030
6.3.4 Mexico Cardiac Biomarkers Testing Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cardiac Biomarkers Testing Revenue, 2018-2030
6.4.2 Germany Cardiac Biomarkers Testing Market Size, 2018-2030
6.4.3 France Cardiac Biomarkers Testing Market Size, 2018-2030
6.4.4 U.K. Cardiac Biomarkers Testing Market Size, 2018-2030
6.4.5 Italy Cardiac Biomarkers Testing Market Size, 2018-2030
6.4.6 Russia Cardiac Biomarkers Testing Market Size, 2018-2030
6.4.7 Nordic Countries Cardiac Biomarkers Testing Market Size, 2018-2030
6.4.8 Benelux Cardiac Biomarkers Testing Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cardiac Biomarkers Testing Revenue, 2018-2030
6.5.2 China Cardiac Biomarkers Testing Market Size, 2018-2030
6.5.3 Japan Cardiac Biomarkers Testing Market Size, 2018-2030
6.5.4 South Korea Cardiac Biomarkers Testing Market Size, 2018-2030
6.5.5 Southeast Asia Cardiac Biomarkers Testing Market Size, 2018-2030
6.5.6 India Cardiac Biomarkers Testing Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cardiac Biomarkers Testing Revenue, 2018-2030
6.6.2 Brazil Cardiac Biomarkers Testing Market Size, 2018-2030
6.6.3 Argentina Cardiac Biomarkers Testing Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cardiac Biomarkers Testing Revenue, 2018-2030
6.7.2 Turkey Cardiac Biomarkers Testing Market Size, 2018-2030
6.7.3 Israel Cardiac Biomarkers Testing Market Size, 2018-2030
6.7.4 Saudi Arabia Cardiac Biomarkers Testing Market Size, 2018-2030
6.7.5 UAE Cardiac Biomarkers Testing Market Size, 2018-2030
7 Cardiac Biomarkers Testing Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Cardiac Biomarkers Testing Major Product Offerings
7.1.4 Abbott Laboratories Cardiac Biomarkers Testing Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Becton, Dickinson and Company
7.2.1 Becton, Dickinson and Company Company Summary
7.2.2 Becton, Dickinson and Company Business Overview
7.2.3 Becton, Dickinson and Company Cardiac Biomarkers Testing Major Product Offerings
7.2.4 Becton, Dickinson and Company Cardiac Biomarkers Testing Revenue in Global Market (2018-2023)
7.2.5 Becton, Dickinson and Company Key News & Latest Developments
7.3 BioMerieux
7.3.1 BioMerieux Company Summary
7.3.2 BioMerieux Business Overview
7.3.3 BioMerieux Cardiac Biomarkers Testing Major Product Offerings
7.3.4 BioMerieux Cardiac Biomarkers Testing Revenue in Global Market (2018-2023)
7.3.5 BioMerieux Key News & Latest Developments
7.4 Bio-Rad Laboratories, Inc.
7.4.1 Bio-Rad Laboratories, Inc. Company Summary
7.4.2 Bio-Rad Laboratories, Inc. Business Overview
7.4.3 Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Major Product Offerings
7.4.4 Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Revenue in Global Market (2018-2023)
7.4.5 Bio-Rad Laboratories, Inc. Key News & Latest Developments
7.5 Danaher Corporation
7.5.1 Danaher Corporation Company Summary
7.5.2 Danaher Corporation Business Overview
7.5.3 Danaher Corporation Cardiac Biomarkers Testing Major Product Offerings
7.5.4 Danaher Corporation Cardiac Biomarkers Testing Revenue in Global Market (2018-2023)
7.5.5 Danaher Corporation Key News & Latest Developments
7.6 ROCHE
7.6.1 ROCHE Company Summary
7.6.2 ROCHE Business Overview
7.6.3 ROCHE Cardiac Biomarkers Testing Major Product Offerings
7.6.4 ROCHE Cardiac Biomarkers Testing Revenue in Global Market (2018-2023)
7.6.5 ROCHE Key News & Latest Developments
7.7 Siemens AG
7.7.1 Siemens AG Company Summary
7.7.2 Siemens AG Business Overview
7.7.3 Siemens AG Cardiac Biomarkers Testing Major Product Offerings
7.7.4 Siemens AG Cardiac Biomarkers Testing Revenue in Global Market (2018-2023)
7.7.5 Siemens AG Key News & Latest Developments
7.8 Thermo Fisher Scientific, Inc.
7.8.1 Thermo Fisher Scientific, Inc. Company Summary
7.8.2 Thermo Fisher Scientific, Inc. Business Overview
7.8.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Major Product Offerings
7.8.4 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Revenue in Global Market (2018-2023)
7.8.5 Thermo Fisher Scientific, Inc. Key News & Latest Developments
7.9 PerkinElmer Inc.
7.9.1 PerkinElmer Inc. Company Summary
7.9.2 PerkinElmer Inc. Business Overview
7.9.3 PerkinElmer Inc. Cardiac Biomarkers Testing Major Product Offerings
7.9.4 PerkinElmer Inc. Cardiac Biomarkers Testing Revenue in Global Market (2018-2023)
7.9.5 PerkinElmer Inc. Key News & Latest Developments
7.10 Tosoh Corporation
7.10.1 Tosoh Corporation Company Summary
7.10.2 Tosoh Corporation Business Overview
7.10.3 Tosoh Corporation Cardiac Biomarkers Testing Major Product Offerings
7.10.4 Tosoh Corporation Cardiac Biomarkers Testing Revenue in Global Market (2018-2023)
7.10.5 Tosoh Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cardiac Biomarkers Testing Market Opportunities & Trends in Global Market
Table 2. Cardiac Biomarkers Testing Market Drivers in Global Market
Table 3. Cardiac Biomarkers Testing Market Restraints in Global Market
Table 4. Key Players of Cardiac Biomarkers Testing in Global Market
Table 5. Top Cardiac Biomarkers Testing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cardiac Biomarkers Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cardiac Biomarkers Testing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cardiac Biomarkers Testing Product Type
Table 9. List of Global Tier 1 Cardiac Biomarkers Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cardiac Biomarkers Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cardiac Biomarkers Testing Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cardiac Biomarkers Testing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cardiac Biomarkers Testing Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Cardiac Biomarkers Testing Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cardiac Biomarkers Testing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cardiac Biomarkers Testing Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Cardiac Biomarkers Testing Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cardiac Biomarkers Testing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cardiac Biomarkers Testing Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cardiac Biomarkers Testing Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cardiac Biomarkers Testing Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cardiac Biomarkers Testing Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cardiac Biomarkers Testing Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cardiac Biomarkers Testing Revenue, (US$, Mn), 2024-2030
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Cardiac Biomarkers Testing Product Offerings
Table 32. Abbott Laboratories Cardiac Biomarkers Testing Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Becton, Dickinson and Company Company Summary
Table 35. Becton, Dickinson and Company Cardiac Biomarkers Testing Product Offerings
Table 36. Becton, Dickinson and Company Cardiac Biomarkers Testing Revenue (US$, Mn) & (2018-2023)
Table 37. Becton, Dickinson and Company Key News & Latest Developments
Table 38. BioMerieux Company Summary
Table 39. BioMerieux Cardiac Biomarkers Testing Product Offerings
Table 40. BioMerieux Cardiac Biomarkers Testing Revenue (US$, Mn) & (2018-2023)
Table 41. BioMerieux Key News & Latest Developments
Table 42. Bio-Rad Laboratories, Inc. Company Summary
Table 43. Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Product Offerings
Table 44. Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Revenue (US$, Mn) & (2018-2023)
Table 45. Bio-Rad Laboratories, Inc. Key News & Latest Developments
Table 46. Danaher Corporation Company Summary
Table 47. Danaher Corporation Cardiac Biomarkers Testing Product Offerings
Table 48. Danaher Corporation Cardiac Biomarkers Testing Revenue (US$, Mn) & (2018-2023)
Table 49. Danaher Corporation Key News & Latest Developments
Table 50. ROCHE Company Summary
Table 51. ROCHE Cardiac Biomarkers Testing Product Offerings
Table 52. ROCHE Cardiac Biomarkers Testing Revenue (US$, Mn) & (2018-2023)
Table 53. ROCHE Key News & Latest Developments
Table 54. Siemens AG Company Summary
Table 55. Siemens AG Cardiac Biomarkers Testing Product Offerings
Table 56. Siemens AG Cardiac Biomarkers Testing Revenue (US$, Mn) & (2018-2023)
Table 57. Siemens AG Key News & Latest Developments
Table 58. Thermo Fisher Scientific, Inc. Company Summary
Table 59. Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Product Offerings
Table 60. Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Revenue (US$, Mn) & (2018-2023)
Table 61. Thermo Fisher Scientific, Inc. Key News & Latest Developments
Table 62. PerkinElmer Inc. Company Summary
Table 63. PerkinElmer Inc. Cardiac Biomarkers Testing Product Offerings
Table 64. PerkinElmer Inc. Cardiac Biomarkers Testing Revenue (US$, Mn) & (2018-2023)
Table 65. PerkinElmer Inc. Key News & Latest Developments
Table 66. Tosoh Corporation Company Summary
Table 67. Tosoh Corporation Cardiac Biomarkers Testing Product Offerings
Table 68. Tosoh Corporation Cardiac Biomarkers Testing Revenue (US$, Mn) & (2018-2023)
Table 69. Tosoh Corporation Key News & Latest Developments
List of Figures
Figure 1. Cardiac Biomarkers Testing Segment by Type in 2022
Figure 2. Cardiac Biomarkers Testing Segment by Application in 2022
Figure 3. Global Cardiac Biomarkers Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cardiac Biomarkers Testing Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cardiac Biomarkers Testing Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cardiac Biomarkers Testing Revenue in 2022
Figure 8. By Type - Global Cardiac Biomarkers Testing Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cardiac Biomarkers Testing Revenue Market Share, 2018-2030
Figure 10. By Type - Global Cardiac Biomarkers Testing Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Cardiac Biomarkers Testing Revenue Market Share, 2018-2030
Figure 12. By Application - Global Cardiac Biomarkers Testing Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Cardiac Biomarkers Testing Revenue Market Share, 2018-2030
Figure 14. By Region - Global Cardiac Biomarkers Testing Revenue Market Share, 2018-2030
Figure 15. By Country - North America Cardiac Biomarkers Testing Revenue Market Share, 2018-2030
Figure 16. US Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Cardiac Biomarkers Testing Revenue Market Share, 2018-2030
Figure 20. Germany Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 21. France Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Cardiac Biomarkers Testing Revenue Market Share, 2018-2030
Figure 28. China Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 32. India Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Cardiac Biomarkers Testing Revenue Market Share, 2018-2030
Figure 34. Brazil Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Cardiac Biomarkers Testing Revenue Market Share, 2018-2030
Figure 37. Turkey Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Cardiac Biomarkers Testing Revenue, (US$, Mn), 2018-2030
Figure 41. Abbott Laboratories Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Becton, Dickinson and Company Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. BioMerieux Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Danaher Corporation Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. ROCHE Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Siemens AG Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. PerkinElmer Inc. Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Tosoh Corporation Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
